Researchers at Mayo Clinic have developed an artificial intelligence framework capable of automatically identifying distant cancer recurrence sites within unstructured electronic health records. Led by Data Science Analyst Madhu Babu Sikha, the project addresses a persistent challenge in oncology research: tracking metastatic progression across fragmented clinical documents. Published in the Journal of Biomedical Informatics, the system represents a targeted application of clinical natural language processing designed to replace time-consuming manual chart reviews with scalable automated extraction. Identifying where breast or prostate cancer spreads typically requires synthesizing data from radiology reports, pathology findings, and physician notes scattered across thousands of pages. These records contain specialized terminology, varying levels of diagnostic certainty, and abbreviations that standard language models often struggle to interpret. The Mayo Clinic framework bypasses structured database fields, instead training directly on the narrative clinical text used by human reviewers. By focusing on contextual cues and cross-document correlations, the model accurately pinpoints metastatic locations such as bone, liver, lung, and brain tissue. To ensure real-world reliability, the team validated the system beyond its development environment using data from Stanford Medicine. The external evaluation confirmed that the framework generalizes effectively across different institutional documentation styles and clinical workflows, indicating it captures fundamental clinical reasoning patterns rather than institution-specific quirks. Notably, the specialized model outperformed several larger, general-purpose large language models, reinforcing an emerging consensus in healthcare AI that task-specific optimization frequently surpasses raw model scale. The research also demonstrated cross-disease adaptability. When applied to prostate cancer records, the breast cancer-trained framework successfully identified recurrence sites without extensive retraining. This suggests the underlying architecture learns broader linguistic and clinical patterns associated with metastatic documentation rather than memorizing disease-specific vocabulary. The broader impact centers on operational efficiency and research acceleration. Hospitals generate vast volumes of unstructured clinical text daily, with critical progression data often locked within narrative notes. Automating the extraction of recurrence sites could significantly reduce the manual burden on cancer registries and outcomes researchers. This shift would reallocate human expertise toward analyzing treatment efficacy and long-term patient outcomes rather than data compilation. While clinical decision-making will always require physician oversight, AI-driven information synthesis presents a scalable solution for routine data organization. Researchers emphasize that transitioning from proof-of-concept to clinical deployment requires rigorous validation across diverse patient populations and close collaboration between data scientists and medical experts. The Mayo Clinic framework demonstrates that focused artificial intelligence can transform fragmented electronic health records into actionable research intelligence, ultimately supporting more precise cancer tracking and improved therapeutic strategies.